Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Technological advances are helping shape the dosage forms of the future.

The Shape of Dosage Forms

Developers need to consider key challenges when approaching accelerated formulation strategies to ensure success.

Successfully Accelerating Formulation Strategies

Ammar Khawam, PhD, is a senior managing scientist of product development at Parsolex.

Process performance metrics of eight different mechanical devices were assessed to evaluate compliance with regulatory and compendial criteria.

Process Performance as a Means of Quality Management

Anand Rajan is head of Sales, ACG Engineering, anand.rajan@acg-world.com.

Smart manufacturing transforms management of tablet and capsule equipment and processes.

Troubleshooting Using Predictive Maintenance

Biocon Biologics will acquire Viatris’ global biosimilars business, including the company’s portfolio of in-licensed biosimilar assets, in a transaction valued at over $3.3 billion.

Biocon Biologics to Acquire Biosimilars Assets from Viatris in $3.3 Billion Deal

AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers as part of AstraZeneca’s Ambition Zero Carbon program. 

AstraZeneca Progresses Ambition Zero Carbon Program with Honeywell Partnership to Develop Next-Generation Respiratory Inhalers

TFF Pharmaceuticals announces findings that inhaled niclosamide significantly inhibits viral replication of the Omicron variant of SARS-CoV-2.

Inhaled Niclosamide Inhibits Viral Replication of the Omicron Variant of SARS-CoV-2

Meg Rivers is the former senior editor for 

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Podcasts

In this episode of the Drug Solutions Podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview Sean Tucker, PhD, chief scientific officer of Vaxart, on developing oral recombinant vaccines.

Drug Solutions Podcast: Developing Oral Recombinant Vaccines

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

PharmTech interviewed Sartorius about SUS innovations and trends.

 Single-Use Systems in Downstream Processes

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates.